Results 291 to 300 of about 10,999,138 (370)

PlantScience.ai: An LLM-Powered Virtual Scientist for Plant Science

Yu H, Zhou S, Huang M, Ding L, Chen Y, Wang Y, Ren Y, Cheng N, Wang X, Liang J, The John Innes Centre and The Sainsbury Laboratory Collaboration, Zhang H, Ding Y, Li K.   +13 more
europepmc   +1 more source

Chemical Bonding: A First-Year Seminar Series that Enhances Chemistry Majors' Perceptions of Chemistry Subdisciplines. [PDF]

ACS Omega
Saenger SL, Nennig HT, Winters J, Wainman JW.   +3 more
europepmc   +1 more source

Exploring Patients’ Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart, Laurène Norberciak, Pascal Richette, Pierre Robinet, Aurore Pacaud, Gauthier Marchasson, Thibault Rabin, Hélène Luraschi, Pierre Maciejasz, Anne‐France Georgel, Augustin Latourte, Hang‐Korng Ea, Sébastien Ottaviani, Charlotte Jauffret, Vincent Ducoulombier   +14 more
wiley   +1 more source

Correction: A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression. [PDF]

Sci Rep
Nakamura H, Watanabe T, Sato A, Kawaguchi A, Uchimaru K, Satou Y, Sueoka E.   +6 more
europepmc   +1 more source

Effectiveness and safety of baricitinib for juvenile idiopathic arthritis associated uveitis or chronic anterior antinuclear antibody positive uveitis

Arthritis Care &Research, Accepted Article.
Objectives Evaluate the efficacy and safety of baricitinib in paediatric patients with active JIA‐U or chronic anterior ANA‐positive uveitis, who had an inadequate response to MTX or bDMARDs. Methods JUVE‐BRIGHT was an open‐label, active‐controlled, Phase‐3 multicentre trial which utilized a novel design, including 1:1 randomization to an active ...
Athimalaipet V. Ramanan, Catherine M. Guly, Gabriele Simonini, Stuart Keller, Priyanka Sen, Thorsten Holzkaemper, Joana Araújo, Pierre Quartier   +7 more
wiley   +1 more source

Correction: CCDC137 knockdown suppresses bladder cancer progression by downregulating SCD. [PDF]

J Transl Med
Zhang H, Huang W, Cai Z, Mou S, Liu Y, Yan B, Jiang W, Liu Y, Mei Q, Liao X, Liu Y, Mei H.   +11 more
europepmc   +1 more source

Sequencing and variant calling of SARS-CoV-2 from floor swabs: a potential tool for identifying emergent lineages. [PDF]

Microb Genom
Hodzic-Santor B, Hinz A, Kassen R, Liu JL, Djambazian H, Lee S, Hicks A, Sjaarda C, Wong H, Sheth PM, Nott C, MacFadden DR, Roy AM, Ragoussis J, Castellani L, Fralick M, Wong A.   +16 more
europepmc   +1 more source

Solid trouble: tau and TDP-43 interaction in aggregation and pathology. [PDF]

EMBO J
Fawzi NL.
europepmc   +1 more source